These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Structure of the Neisserial outer membrane protein Opa₆₀: loop flexibility essential to receptor recognition and bacterial engulfment. Fox DA; Larsson P; Lo RH; Kroncke BM; Kasson PM; Columbus L J Am Chem Soc; 2014 Jul; 136(28):9938-46. PubMed ID: 24813921 [TBL] [Abstract][Full Text] [Related]
26. Carcinoembryonic antigen family receptor recognition by gonococcal Opa proteins requires distinct combinations of hypervariable Opa protein domains. Bos MP; Kao D; Hogan DM; Grant CC; Belland RJ Infect Immun; 2002 Apr; 70(4):1715-23. PubMed ID: 11895933 [TBL] [Abstract][Full Text] [Related]
27. CGM1a antigen of neutrophils, a receptor of gonococcal opacity proteins. Chen T; Gotschlich EC Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14851-6. PubMed ID: 8962144 [TBL] [Abstract][Full Text] [Related]
30. Pathogenic neisseriae--a model of bacterial virulence and genetic flexibility. Meyer TF Zentralbl Bakteriol; 1990 Nov; 274(2):135-54. PubMed ID: 2085368 [TBL] [Abstract][Full Text] [Related]
31. Contacting the host: insights and implications of pathogenic Neisseria cell interactions. Plant L; Jonsson AB Scand J Infect Dis; 2003; 35(9):608-13. PubMed ID: 14620143 [TBL] [Abstract][Full Text] [Related]
32. The structural basis of CEACAM-receptor targeting by neisserial opa proteins: response. Virji M Trends Microbiol; 2000 Jun; 8(6):260-1. PubMed ID: 10838581 [No Abstract] [Full Text] [Related]
33. Neisseria and neisserial infections. SCHERP HW Annu Rev Microbiol; 1955; 9():319-34. PubMed ID: 13259469 [No Abstract] [Full Text] [Related]
34. Transcriptional and immunological analysis of the putative outer membrane protein and vaccine candidate TprL of Treponema pallidum. Haynes AM; Fernandez M; Romeis E; Mitjà O; Konda KA; Vargas SK; Eguiluz M; Caceres CF; Klausner JD; Giacani L PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008812. PubMed ID: 33497377 [TBL] [Abstract][Full Text] [Related]
35. Virulence Factors of Meningitis-Causing Bacteria: Enabling Brain Entry across the Blood-Brain Barrier. Herold R; Schroten H; Schwerk C Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671896 [TBL] [Abstract][Full Text] [Related]
36. A journey into the brain: insight into how bacterial pathogens cross blood-brain barriers. Coureuil M; Lécuyer H; Bourdoulous S; Nassif X Nat Rev Microbiol; 2017 Mar; 15(3):149-159. PubMed ID: 28090076 [TBL] [Abstract][Full Text] [Related]
37. Characterisation of the Immunomodulatory Effects of Meningococcal Opa Proteins on Human Peripheral Blood Mononuclear Cells and CD4+ T Cells. Jones C; Sadarangani M; Lewis S; Payne I; Saleem M; Derrick JP; Pollard AJ PLoS One; 2016; 11(4):e0154153. PubMed ID: 27111850 [TBL] [Abstract][Full Text] [Related]
38. Phase variation of Opa proteins of Neisseria meningitidis and the effects of bacterial transformation. Sadarangani M; Hoe CJ; Makepeace K; van der Ley P; Pollard AJ J Biosci; 2016 Mar; 41(1):13-9. PubMed ID: 26949083 [TBL] [Abstract][Full Text] [Related]
39. Transcriptional landscape and essential genes of Neisseria gonorrhoeae. Remmele CW; Xian Y; Albrecht M; Faulstich M; Fraunholz M; Heinrichs E; Dittrich MT; Müller T; Reinhardt R; Rudel T Nucleic Acids Res; 2014; 42(16):10579-95. PubMed ID: 25143534 [TBL] [Abstract][Full Text] [Related]
40. Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa. Pajon R; Fergus AM; Granoff DM PLoS One; 2013; 8(6):e66536. PubMed ID: 23805230 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]